Similar articles

• Selective COX-2 inhibitors: a promise unfulfilled?

  Henry D, McGettigan P. Henry D, et al. Gastroenterology. 2007 Feb;132(2):790-4. doi: 10.1053/j.gastro.2007.01.017. Gastroenterology. 2007. PMID: 17261306 No abstract available.
• [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2004 Mar 25;146(13):61. MMW Fortschr Med. 2004. PMID: 15219139 German. No abstract available.
• Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.

  Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA. Vonkeman HE, et al. Arthritis Res Ther. 2007;9(3):R52. doi: 10.1186/ar2207. Arthritis Res Ther. 2007. PMID: 17521422 Free PMC article.
• [Non-steroid anti-inflammatory agents and digestive tract lesions].

  Lanas Arbeloa AI, Hirschowitz BI. Lanas Arbeloa AI, et al. Rev Esp Enferm Dig. 1993 Nov;84(5):326-35. Rev Esp Enferm Dig. 1993. PMID: 8305260 Review. Spanish. No abstract available.
• Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.

  Bjorkman DJ, Kimmey MB. Bjorkman DJ, et al. Dig Dis. 1995 Mar-Apr;13(2):119-29. doi: 10.1159/000171493. Dig Dis. 1995. PMID: 7586632 Review.